Microbiome models with clinical strains, for reliable results
The Biomillenia microbiome models enable testing cosmetic ingredients to characterize their impact on skin’s microbial ecosystem, at high throughput. At all stages of your development, it will provide:
Biomillenia’s microbiome-on-a-chip platform captures the vast diversity of the microbiota using microfluidic single cell droplet cultures. Bacterial cells grow to monoclonal cultures in millions of parallel cultures. As a result:
Precise data, on relevant skin microbiome clinical strains
Fast results in 4 weeks, in a cost-effective manner
Easy communication of results with your customers, with our microbiome score!
The only microbiome model based on clinical data
Via a two-year research project, Biomillenia, a subsidiary of a pharmaceutical company, has developed the only skin microbiome models that assess the impact of ingredients on representative clinical microbiome strains.
In a clinical trial run in Europe and approved by EU authorities, Biomillenia sampled multiple body sites from 44 volunteers with diverse skin phenotypes, ages and genders. Samples allowed the following information to be generated:
A detailed sequencing dataset at unprecedented taxonomic resolution; giving the most detailed picture of prevalence, abundance, and diversity of skin commensals across the full cohort
A unique strain bank of clinical strains to enable ingredient testing
Based on this work, panels of consumer-derived microorganisms, representative of the in vivo microbiomes of the 44 participants were finally selected, opening the way to fast and reliable in vitro testing for cosmetic product ingredients targeting 2 body sites:
